Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Blood Component Removal × 90 days × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 1 Solid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neoplasms 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Blast Crisis 1

Interventions

Dasatinib 3 nilotinib 2 asciminib 2 ruxolitinib 1 ponatinib 1 pembrolizumab 1 decitabine and cedazuridine drug combination 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Practice Management, Medical 1 Polymerase Chain Reaction 1 Mycophenolic Acid 1 Methotrexate 1 Interviews as Topic 1 Imatinib Mesylate 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cyclosporine 1 Cyclophosphamide 1 Blood Specimen Collection 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡